Concinnity Labs identifies high-value problems where AI creates outsized impact — then builds, deploys, and scales the solution. ONMD is live inside Epic today. This is the first product of a platform built to keep shipping.
Concinnity Labs builds AI where the gap between what happens and what gets recorded costs the most. ONMD is our first deployment. The architecture that powers it is the foundation for everything that follows.
Physicians catch the clinical finding. It does not always make it into the chart — not because they are not paying attention, but because documenting clinical complexity during active patient care is genuinely hard. ONMD runs silently alongside the clinician, surfacing a consolidated pre-discharge documentation review at exactly the right moment. No mid-round interruptions. No alert fatigue. One high-yield review before the patient leaves the building. Patent pending.
ONMD bypasses 18-month hospital procurement cycles entirely. Any physician can connect their Epic account in under 2 minutes at onmd.ai — no IT approval, no contract, no cost. Viral physician adoption drives hospital enterprise conversion.
ONMD supports accurate clinical documentation only. All documentation decisions remain exclusively with the treating physician.
NOVA is the architectural proof that the Concinnity Labs platform works. A whole-home AI companion that routes queries across specialized AI models in real time — with persistent memory and adaptive response. The intelligence layer it demonstrates powers everything we build. Patent pending.
We are actively evaluating the next high-value deployment target. Concinnity Labs builds where the documentation gap, the intelligence gap, or the automation gap is largest — and where AI can close it faster than any alternative. If you are working on a problem that fits that profile, we want to hear from you.
Investor & Partner Inquiries → mike@concinnitylabs.comClinical documentation is one of the largest and most consistently overlooked sources of revenue leakage in US healthcare. The market to close it is validated — over $1B+ invested in ambient clinical AI in 2025 alone. Every dollar went to retrospective solutions. ONMD is the first product built to work before discharge.
ONMD is free for individual physicians — no procurement cycle, no IT approval required. Physicians adopt it. Departments follow. Enterprises contract. The model moves from individual adoption to enterprise revenue without requiring a single cold sales call into hospital procurement.
The model projects $12.5M ARR at 50 hospitals. Full financial detail available to qualified investors on request.
Seven structural advantages — each one a function of how Concinnity Labs is built, not just what it has built.
Mike Roark spent 8 years as a medical device specialist inside hospital operating rooms, catheterization labs, and interventional suites across Cincinnati and Northern Kentucky. Every day he watched the same thing happen — physicians delivering excellent care that never made it into the chart correctly. Revenue walked out the door. Documentation gaps accumulated. Billing teams caught it weeks later.
He built ONMD because he knew exactly what was missing — and exactly who needed it. Not a product built from the outside looking in. A product built by someone who watched the problem happen in real time, for eight years, in the same health systems ONMD now targets.
Two products. Two patents. Zero outside capital.
ONMD is live. The architecture is proven. The market is validated. This raise funds the three milestones that unlock enterprise contracts.
These three milestones are the foundation for the seed round. Full financial projections, cap table, and deal terms available to qualified investors on request.
Executive summary and product overview available on request.
mike@concinnitylabs.comInvestors, physicians, health systems, and potential portfolio partners are welcome. We respond to every inquiry.
mike@concinnitylabs.com